Healthcare provider profile · identity verified

Timothy J Hunter, M.D.

Family Practice · WEST BURLINGTON, IA · NPI 1922003003

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	597	137
Levothyroxine Sodium	Levothyroxine Sodium	433	97
Lisinopril	Lisinopril	319	70
Amlodipine Besylate	Amlodipine Besylate	312	73
Simvastatin	Simvastatin	249	60
Losartan Potassium	Losartan Potassium	226	60
Omeprazole	Omeprazole	218	51
Metformin Hcl	Metformin Hcl	217	53
Furosemide	Furosemide	213	48
Potassium Chloride	Potassium Chloride	186	39
Gabapentin	Gabapentin	183	44
Metoprolol Tartrate	Metoprolol Tartrate	176	42
Rosuvastatin Calcium	Rosuvastatin Calcium	152	41
Metoprolol Succinate	Metoprolol Succinate	142	37
Hydrochlorothiazide	Hydrochlorothiazide	141	35
Citalopram Hbr	Citalopram Hydrobromide	136	32
Glimepiride	Glimepiride	131	28
Famotidine	Famotidine	128	25
Eliquis	Apixaban	124	19
Tamsulosin Hcl	Tamsulosin Hcl	118	34
Pantoprazole Sodium	Pantoprazole Sodium	108	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	103	34
Warfarin Sodium	Warfarin Sodium	103	25
Sertraline Hcl	Sertraline Hcl	101	27
Albuterol Sulfate Hfa	Albuterol Sulfate	92	31
Prednisone	Prednisone	82	43
Pravastatin Sodium	Pravastatin Sodium	81	17
Tramadol Hcl	Tramadol Hcl	72	30
Allopurinol	Allopurinol	69	19
Alprazolam	Alprazolam	66	22
Donepezil Hcl	Donepezil Hcl	65	11
Glipizide	Glipizide	64	16
Jardiance	Empagliflozin	64	suppressed
Trazodone Hcl	Trazodone Hcl	62	16
Ezetimibe	Ezetimibe	60	15
Atenolol	Atenolol	56	14
Meloxicam	Meloxicam	54	17
Fluticasone Propionate	Fluticasone Propionate	50	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	49	13
Fluoxetine Hcl	Fluoxetine Hcl	48	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	47	suppressed
Metformin Hcl Er	Metformin Hcl	47	14
Clopidogrel	Clopidogrel Bisulfate	46	14
Spironolactone	Spironolactone	46	14
Trulicity	Dulaglutide	42	suppressed
Enalapril Maleate	Enalapril Maleate	39	11
Finasteride	Finasteride	38	suppressed
Ozempic	Semaglutide	38	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Azithromycin	Azithromycin	36	29
Duloxetine Hcl	Duloxetine Hcl	35	suppressed
Benazepril Hcl	Benazepril Hcl	34	suppressed
Carvedilol	Carvedilol	34	suppressed
Ventolin Hfa	Albuterol Sulfate	33	suppressed
Baclofen	Baclofen	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Humalog	Insulin Lispro	31	suppressed
Clonazepam	Clonazepam	29	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Lovastatin	Lovastatin	27	suppressed
Pregabalin	Pregabalin	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	11
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	24	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Nystatin	Nystatin	23	14
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Oxycodone Hcl	Oxycodone Hcl	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Irbesartan	Irbesartan	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	17
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Propafenone Hcl	Propafenone Hcl	20	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	20	suppressed
Cephalexin	Cephalexin	19	17
Escitalopram Oxalate	Escitalopram Oxalate	19	suppressed
Gemfibrozil	Gemfibrozil	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Primidone	Primidone	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Celecoxib	Celecoxib	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Amoxicillin	Amoxicillin	15	15
Breyna	Budesonide/Formoterol Fumarate	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	12
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	13
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Norgestimate-Ethinyl Estradiol	Norgestimate-Ethinyl Estradiol	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Pentoxifylline	Pentoxifylline	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error